A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients
A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients
Recruiting · NCT02852213 · Registry updated 2026-08-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients | aromatic L-amino acid decarboxylase deficiency | Recruiting | Phase 1 | 2026-08-27 | NCT02852213 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Krzysztof Bankiewicz | 2 |
| National Institute of Neurological Disorders and Stroke (NINDS) | 370 |
| University of California, San Francisco | 637 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Nationwide Children's Hospital | Columbus | United States | 309 |
| The Ohio State University Medical Center | Columbus | United States | 2 |
| University of California San Francisco, Benioff Children's Hospital | San Francisco | United States | 2 |